Psychotic Disorders - Honduras | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$6.22m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.08%, resulting in a market volume of US$6.56m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$51.36 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Honduras is experiencing steady growth due to increasing customer preferences for effective treatment options and a growing awareness of mental health issues.

Customer preferences: Customers in the Psychotic Disorders market in Honduras are increasingly seeking effective treatment options that can alleviate symptoms and improve their quality of life. They are looking for medications that can effectively manage symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, customers prefer treatments that have minimal side effects and are easy to administer. They also value therapies and counseling services that can help them cope with their condition and improve their overall well-being.

Trends in the market: One of the key trends in the Psychotic Disorders market in Honduras is the increasing availability and affordability of antipsychotic medications. Pharmaceutical companies are expanding their presence in the country, making a wider range of medications accessible to customers. This trend is driven by the growing demand for effective treatments and the efforts of healthcare providers to improve access to mental health services. Additionally, there is a growing trend towards integrated care, where healthcare providers collaborate with mental health professionals to provide comprehensive treatment plans for individuals with psychotic disorders.

Local special circumstances: Honduras faces unique challenges in the treatment of psychotic disorders. The country has limited healthcare infrastructure and resources, particularly in rural areas. This can hinder access to diagnosis and treatment services, leading to delays in receiving appropriate care. Furthermore, there is a stigma associated with mental health issues in Honduran society, which can discourage individuals from seeking help or adhering to treatment plans. Efforts are being made to address these challenges by improving mental health services and raising awareness about the importance of seeking treatment.

Underlying macroeconomic factors: The growth of the Psychotic Disorders market in Honduras is influenced by several macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in healthcare spending. This has allowed for the expansion of mental health services and the availability of more treatment options for individuals with psychotic disorders. Additionally, the government has implemented policies and initiatives to improve mental health care, including the integration of mental health services into primary care settings. These factors have contributed to the growth of the market in Honduras.In conclusion, the Psychotic Disorders market in Honduras is witnessing growth due to increasing customer preferences for effective treatment options, a growing awareness of mental health issues, and the efforts of healthcare providers and the government to improve access to mental health services. However, challenges such as limited healthcare infrastructure and stigma surrounding mental health still need to be addressed to ensure that individuals with psychotic disorders receive the care they need.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.